Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | ENPEP | Q07075 | 6/20 | 0.61 |
| ▸ | ANPEP | P15144 | 3/20 | 0.61 |
| ▸ | GABRP | O00591 | 2/20 | 0.56 |
| ▸ | GABRD | O14764 | 2/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.56 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.56 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.56 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.56 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.56 |
| ▸ | GABRE | P78334 | 2/20 | 0.56 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.56 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.56 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.56 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.56 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL289090 | 0.87 | ENPEP (0.76) | ALDH1A1ENPEPANPEPGABRPGABRD | |
| SCHEMBL289085 | 0.86 | ALDH1A1 (0.66) | ALDH1A1ENPEPANPEPGABRPGABRD | |
| SCHEMBL157617 | 0.86 | ALDH1A1 (0.66) | ALDH1A1ENPEPANPEPGABRPGABRD | |
| SCHEMBL466531 | 0.86 | ALDH1A1 (0.85) | ALDH1A1ENPEPMEN1TSHRKMT2A | |
| SCHEMBL8509937 | 0.85 | ALDH1A1 (0.69) | ALDH1A1ENPEPANPEPS1PR2S1PR1 | |
| SCHEMBL1877095 | 0.85 | ALDH1A1 (0.69) | ALDH1A1ENPEPANPEPS1PR2S1PR1 | |
| SCHEMBL1873964 | 0.85 | ALDH1A1 (0.96) | ALDH1A1ENPEPMEN1TSHRKMT2A | |
| SCHEMBL288475 | 0.83 | — | — | |
| SCHEMBL900872 | 0.83 | — | — | |
| SCHEMBL5194202 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1380064-A | Method for producing antibiotic preparation and its application | HERAEUS GUSA GMBH & CO KG (DE) | 2002-11-20 | — | — | CN | claimed |
| CN-110072883-A | The relevant peptide of therapeutic MOTS-C | 科巴公司 | 2019-07-30 | — | — | CN | disclosed |
| US-20190046600-A1 | COMPOSITIONS AND USES THEREOF | WARENIUS HILMAR M (GB) | 2019-02-14 | — | — | US | disclosed |
| EP-3414326-A1 | COMPOSITIONS AND USES THEREOF | Warenius, Hilmar M (GB) | 2018-12-19 | — | — | EP | disclosed |
| US-20170313746-A1 | Peptides Useful For Treating Cancer | WARENIUS HILMAR M (GB) | 2017-11-02 | — | — | US | disclosed |
| WO-2017137761-A1 | COMPOSITIONS AND USES THEREOF | WARENIUS HILMAR M (GB) | 2017-08-17 | — | — | WO | disclosed |
| EP-3177716-A1 | PEPTIDES USEFUL FOR TREATING CANCER | Warenius, Hilmar M (GB) | 2017-06-14 | — | — | EP | disclosed |
| WO-2016020437-A1 | PEPTIDES USEFUL FOR TREATING CANCER | WARENIUS HILMAR M (GB) | 2016-02-11 | — | — | WO | disclosed |
| EP-2305282-B1 | Prevention and treatment of amyloidogenic disease | JANSSEN ALZHEIMER IMMUNOTHERAP (IE) | 2013-07-10 | — | — | EP | disclosed |
| WO-2011086565-A1 | METHOD FOR PREPARATION OF ENANTIOMERICALLY ENRICHED AND/OR RACEMIC GAMMA-AMINO ACIDS | LUPIN LIMITED (IN) | 2011-07-21 | — | — | WO | disclosed |
| EP-0738154-A1 | N-TERMINUS MODIFIED ANALOGS OF LHRH | Abbott Laboratories (US) | 1996-10-23 | — | — | EP | disclosed |
| EP-0738154-A4 | N-TERMINUS MODIFIED ANALOGS OF LHRH | ABBOTT LAB (US) | 1996-04-12 | — | — | EP | disclosed |
| US-5502035-A | N-terminus modified analogs of LHRH | TAP HOLDINGS INC. (US) | 1996-03-26 | — | — | US | disclosed |
| EP-0592732-B1 | Liquid transfer tube | NITTA MOORE CO LTD (JP) | 1995-12-27 | — | — | EP | disclosed |
| WO-1995004541-A1 | N-TERMINUS MODIFIED ANALOGS OF LHRH | ABBOTT LABORATORIES (US) | 1995-02-16 | — | — | WO | disclosed |
| US-5330810-A | Liquid transfer tube | NITTA MOORE COMPANY (JP) | 1994-07-19 | — | — | US | disclosed |
| EP-0592732-A1 | Liquid transfer tube | NITTA MOORE COMPANY (JP) | 1994-04-20 | — | — | EP | disclosed |
| US-4957980-A | POLYAMIDE-POLYESTER BLEND, COMPATIBILIZING AGENT | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1990-09-18 | — | — | US | disclosed |
| US-4812163-A | Phenoxyacetic acids and herbicides comprising them as active ingredients | TEIJIN, LIMITED (JP) | 1989-03-14 | — | — | US | disclosed |
| US-4398642-A | MULTILAYER; THERMOPLASTIC POLYESTERS AND POLYAMIDES LAYERS | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1983-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190046600-A1 | COMPOSITIONS AND USES THEREOF | LDHA, PARP1, LDHB | ALDH1A1 58/4885ENPEP 857/4885ANPEP 2635/4885 |
| US-20170313746-A1 | Peptides Useful For Treating Cancer | PARP1, PARP3, LNPEP | ALDH1A1 2496/4885ENPEP 24/4885ANPEP 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.